Fig. 8From: A high-throughput screening system for SARS-CoV-2 entry inhibition, syncytia formation and cell toxicityScreening with rVSV-G-GFP infection. Graph showing rVSV-G-GFP inhibition streptonigrin, Didemnin B treatment. 17-Aminodemethoxy geldanamycin, scillaren A, Proscillaridin, and Acetoxycyclohexamide showed moderate inhibition. Graph mean ± SD, n = 3Back to article page